DDN - Horizon - John Moffat by DDN News published on 2020-07-24T21:05:08Z John Moffat, senior scientist in Biochemical and Cellular Pharmacology at Genentech, discusses the target validation and prioritization opportunities revealed at the crossroads of target-focused and phenotypic profiling approaches.